Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.375
Bid: 7.25
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.25 (3.448%)
Open: 7.375
High: 7.375
Low: 7.375
Prev. Close: 7.375
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IXICO plc announces SBRI Healthcare contract

16 Apr 2014 07:00

RNS Number : 9231E
IXICO plc
16 April 2014
 



16 April 2014

 

 

IXICO plc announces SBRI Healthcare development contract

 

IXICO plc (Ticker: IXI) ("IXICO" or the "Company"), the brain health company, announces that it has been awarded a development contract by SBRI Healthcare (The Small Business Research Initiative for Healthcare) to cover Phase 1 funding for the development of an online application designed to support dementia sufferers post-diagnosis.

Receiving a dementia diagnosis is inevitably traumatic for patients and far too often, patients and their families receive very little support until there is a crisis. This development project will build on Assessa™, IXICO's digital healthcare platform to support dementia diagnosis, to address post-diagnostic care planning and support. It aims to harness web and mobile technologies to provide ongoing support and to assist those living with dementia as well as their families, carers and healthcare professionals. The goal is to prolong and enhance independent living by facilitating improved self-care with full interaction with the relevant healthcare professionals and other support agencies. Social media concepts will be adapted to build a personal management tool whereby diagnosis is carefully linked to continuing care-planning and support. This will then aid the transition into other care settings by travelling with the patient and relatives throughout the course of the illness.

The project will be led by IXICO in partnership with the Health Innovation Network South London. (www.hin-southlondon.org)

Commenting on the award, Derek Hill, CEO of IXICO said:

 

'We are delighted to receive this support from SBRI Healthcare which will help us to extend the potential patient benefit of Assessa™ following diagnosis and is central to the widening of our digital healthcare offering. We look forward to working with the Health Innovation Network to improve the care of dementia sufferers.'

 

Commenting on the award, Dr Hugo DeWaal, Clinical Director for Dementia at the Health Innovation Network said:

 

'Dementia is a key health and social care priority, and the Health Innovation Network is keen to develop a tool that is helpful for people with dementia, their families and carers. We hope that this partnership and SBRI funding will allow us to rapidly improve dementia care for a greater number of people.'

About SBRI Healthcare

The Small Business Research Initiative for Healthcare (SBRI Healthcare) is an NHS England initiative, championed by the newly formed Academic Health Science Networks (AHSNs), that aim to promote UK economic growth whilst addressing unmet health needs and enhancing the take up of known best practice. Part of Innovation Health and Wealth, the SBRI Healthcare programme sets industry the challenge in a series of health related competitions which result in fully funded development contracts between the awarded company and the NHS. Unlike many R&D projects which offer grant or match funding, SBRI contracts are 100 per cent funded and the company retains the IP.

More information is available on www.sbrihealthcare.co.uk

About IXICO

IXICO, the brain health company, was founded in 2004 with a mission to translate image acquisition, management and analysis technology and know-how, which the founders had developed together, into commercial products targeting the expanding area of imaging to inform decision-making during drug development. This has resulted in commercially successful products being launched in the clinical trials (Phase 0-III) and experimental medicine markets and more recently launched into the wider clinical diagnostic market. Since incorporation, IXICO has been awarded contracts by nine of the top 15 global pharmaceutical companies as well as leading biotechnology companies. In October 2013, IXICO plc was admitted to trading on AIM. More information is available on www.ixico.com

About the Health Innovation Network

The Health Innovation Network is a membership organisation, driving lasting improvements in health and wellbeing across South London by sharing innovations across the health system and capitalising on teaching and research strengths. Founded by NHS England, the Health Innovation Network is the Academic Health Science Network (AHSN) for South London. We are focusing on health priorities for our local communities across a number of clinical areas and cross-cutting innovation themes, including dementia, diabetes, musculoskeletal, alcohol and cancer. www.hin-southlondon.org 

 

Enquiries:

 

IXICO plc

Derek Hill, CEO

Charles Spicer, VP Corporate Development

+44 20 7691 2064

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel

Clare Terlouw

+44 20 7418 8900

 

Daniel Stewart & Company (Joint Broker)

Mark Treharne

David Hart

+44 207 776 6550

 

FTI Consulting Limited (Investor Relations)

Ben Atwell

Simon Conway

John Dineen

+44 20 3727 1000 

 

Health Innovation Network

Anna King, Commercial Director

+44 20 7188 7188

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASFDEDIFLSEFL
Date   Source Headline
3rd Jan 201212:00 pmRNSBlocklisting Interim Review
28th Nov 201110:09 amRNSDirector/PDMR Shareholding
28th Nov 201110:08 amRNSDirector/PDMR Shareholding
24th Nov 20117:00 amRNSFinal Results
7th Nov 20118:51 amRNSBlocklisting Interim Review
4th Oct 20117:00 amRNSResearch Update
29th Sep 20117:00 amRNSResearch Update
16th Aug 20117:00 amRNSInterim Management Statement
28th Jul 20117:31 amRNSResearch Update
12th Jul 201112:04 pmRNSBlocklisting Interim Review
5th Jul 201112:04 pmRNSTotal Voting Rights
17th Jun 20113:28 pmRNSBlocklisting Interim Review
26th May 20117:00 amRNSHalf Yearly Report
17th May 20118:35 amRNSNotice of Results
5th May 20117:00 amRNSBlocklisting Interim Review
31st Mar 20119:07 amRNSResult of AGM
2nd Mar 201112:27 pmRNSHolding(s) in Company
15th Feb 20117:00 amRNSInterim Management Statement
7th Feb 201112:18 pmRNSAnnual Information Update
1st Feb 20118:54 amRNSTotal Voting Rights
1st Feb 20118:53 amRNSAnnual Financial Report & Notice of AGM
19th Jan 20112:14 pmRNSDirector/PDMR Shareholding
19th Jan 20112:14 pmRNSDirector/PDMR Shareholding
14th Jan 201110:18 amRNSHolding(s) in Company
10th Jan 201111:45 amRNSHolding(s) in Company
7th Jan 20111:50 pmRNSBlock Listing Application
7th Jan 201110:59 amRNSBlocklisting Application
4th Jan 20112:01 pmRNSTotal Voting Rights
21st Dec 201012:19 pmRNSDirector/PDMR Shareholding
21st Dec 201012:18 pmRNSDirector/PDMR Shareholding
14th Dec 20101:15 pmRNSBlock Listing Application
30th Nov 20107:00 amRNSFinal Results
17th Nov 201011:44 amRNSResearch Update
3rd Nov 20109:29 amRNSBlocklisting Interim Review
1st Nov 20104:31 pmRNSPreliminary Results - Change of Date
1st Nov 201010:41 amRNSNotice of Results
29th Sep 20102:00 pmRNSPresents Cogane data at scientific conferences
18th Aug 20107:00 amRNSInterim Management Statement
22nd Jul 20101:49 pmRNSDirector/PDMR Shareholding
22nd Jul 20101:49 pmRNSDirector/PDMR Shareholding
5th Jul 201010:59 amRNSChange of Registered Office
21st Jun 20107:00 amRNSAppointment of Chief Executive Officer
14th Jun 20107:00 amRNSRegulatory Approval to Begin Cogane PII Trial
24th May 20107:00 amRNSHalf Yearly Report
19th May 20104:25 pmRNSNotice of Results
4th May 20102:13 pmRNSBlocklisting Interim Review
1st Apr 201012:36 pmRNSDirector/PDMR Shareholding
1st Apr 201012:35 pmRNSDirector/PDMR Shareholding
1st Apr 201012:34 pmRNSDirector/PDMR Shareholding
31st Mar 201012:19 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.